Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL)
CUSIP: 05280R100
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / American Depositary Shares, each representing one ordinary share, par value $0.000042 per share
- Shares outstanding
- 265,957,447
- Total 13F shares
- 178,106,548
- Share change
- +2,530,863
- Total reported value
- $619,765,055
- Put/Call ratio
- 57%
- Price per share
- $3.48
- Number of holders
- 106
- Value change
- -$54,511,638
- Number of buys
- 54
- Number of sells
- 51
Quarterly Holders Quick Answers
What is CUSIP 05280R100?
CUSIP 05280R100 identifies AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05280R100:
Top shareholders of AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Syncona Portfolio Ltd |
13F
|
Company |
8%
|
21,346,829
|
$136,192,769 | — | 31 Mar 2024 | |
| Blackstone Inc. |
13F
|
Company |
7.7%
|
20,485,611
|
$130,698,198 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
5.7%
|
15,272,172
|
$97,436,457 | — | 31 Mar 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.6%
|
12,345,678
|
$78,765,426 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
4%
|
10,763,001
|
$68,667,947 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
3.4%
|
9,016,390
|
$57,524,568 | — | 31 Mar 2024 | |
| Tetragon Partners GP Ltd |
13F
|
Company |
2.8%
|
7,525,682
|
$48,013,851 | — | 31 Mar 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.5%
|
6,616,667
|
$42,214,335 | — | 31 Mar 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
2.4%
|
6,425,803
|
$40,996,623 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.1%
|
5,488,986
|
$35,020,000 | — | 31 Mar 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
1.8%
|
4,672,000
|
$29,807,360 | — | 31 Mar 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.7%
|
4,623,324
|
$29,496,807 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.6%
|
4,330,745
|
$27,630,153 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.5%
|
4,055,920
|
$25,876,769 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.4%
|
3,639,000
|
$23,216,820 | — | 31 Mar 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
1.3%
|
3,375,000
|
$21,532,500 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.2%
|
3,200,000
|
$20,416,000 | — | 31 Mar 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
1.1%
|
2,965,721
|
$18,921,300 | — | 31 Mar 2024 | |
| Commodore Capital LP |
13F
|
Company |
0.86%
|
2,300,000
|
$14,674,000 | — | 31 Mar 2024 | |
| Perpetual Ltd |
13F
|
Company |
0.84%
|
2,234,515
|
$14,256,206 | — | 31 Mar 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.79%
|
2,090,471
|
$13,337,205 | — | 31 Mar 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.63%
|
1,672,732
|
$10,672,030 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.55%
|
1,450,791
|
$9,256,046 | — | 31 Mar 2024 | |
| Lynx1 Capital Management LP |
13F
|
Company |
0.52%
|
1,390,160
|
$8,869,221 | — | 31 Mar 2024 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.45%
|
1,196,876
|
$7,636,069 | — | 31 Mar 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.44%
|
1,166,667
|
$7,443,335 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.39%
|
1,039,677
|
$6,633,141 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.39%
|
1,032,988
|
$6,590,463 | — | 31 Mar 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.31%
|
828,761
|
$5,287,495 | — | 31 Mar 2024 | |
| Alphabet Inc. |
13F
|
Company |
0.26%
|
698,262
|
$4,454,911 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.26%
|
690,473
|
$4,405,218 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.26%
|
686,480
|
$4,379,742 | — | 31 Mar 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.25%
|
676,025
|
$4,313,040 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.24%
|
646,959
|
$4,127,598 | — | 31 Mar 2024 | |
| LGT CAPITAL PARTNERS LTD. |
13F
|
Company |
0.21%
|
550,000
|
$3,509,000 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
512,847
|
$3,271,964 | — | 31 Mar 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.19%
|
500,000
|
$3,190,000 | — | 31 Mar 2024 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.18%
|
492,000
|
$3,138,960 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.16%
|
429,152
|
$2,737,989 | — | 31 Mar 2024 | |
| NOMURA ASSET MANAGEMENT CO LTD |
13F
|
Company |
0.14%
|
384,796
|
$2,454,998 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.14%
|
380,528
|
$2,427,769 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.14%
|
376,772
|
$2,403,806 | — | 31 Mar 2024 | |
| MAI Capital Management |
13F
|
Company |
0.13%
|
354,306
|
$2,260,472 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.13%
|
342,406
|
$2,184,550 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.12%
|
323,900
|
$2,066,000 | — | 31 Mar 2024 | |
| HARBOR CAPITAL ADVISORS, INC. |
13F
|
Company |
0.11%
|
279,820
|
$1,785,000 | — | 31 Mar 2024 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.1%
|
273,929
|
$1,748,000 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.1%
|
261,526
|
$1,668,536 | — | 31 Mar 2024 | |
| HighVista Strategies LLC |
13F
|
Company |
0.1%
|
261,324
|
$1,667,247 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.09%
|
228,842
|
$1,460,012 | — | 31 Mar 2024 |
Institutional Holders of Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) as of Q2 2024
As of 30 Jun 2024,
Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) was held by
106 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
178,106,548 shares.
The largest 10 holders included
Syncona Portfolio Ltd, Blackstone Inc., WELLINGTON MANAGEMENT GROUP LLP, Deep Track Capital, LP, Avoro Capital Advisors LLC, FMR LLC, TFG Asset Management GP Ltd, ARMISTICE CAPITAL, LLC, Frazier Life Sciences Management, L.P., and BlackRock Inc..
This page lists
108
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
114
Q2 2024 holders
106
Holder diff
-8
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.